Skip to main content
. 2013 Aug 2;5:205–214. doi: 10.2147/CMAR.S45236

Table 3.

Key primary and secondary outcome measures by country (Italy, Austria, and overall)

Italy (n = 1130) Austria (n = 282) Overall (n = 1412)
Prevalence
 Anemic – n (%) 347 (31) 101 (36) 448 (32)
 95% CI 28.1, 33.5 30.4, 41.6 29.4, 34.2
Type of visit – n (%)
 Outpatient 517 (46) 168 (60) 685 (49)
 Hospitalized 613 (54) 114 (40) 727 (51)
Reason for visita – n (%)
 Chemotherapy administration 698 (62) 193 (68) 891 (63)
 Anemia treatment 43 (4) 9 (3) 52 (4)
 Other cancer or chemotherapy-related reason 398 (35) 86 (30) 484 (34)
 Other reason not related to cancer 14 (1) 6 (2) 20 (1)
Hemoglobin results
 n (%) 905 (80) 248 (88) 1153 (82)
 Mean (SD) – g/dL 11.7 (1.7) 11.7 (1.7) 11.7 (1.7)
Hemoglobin category – n (%)
 ≤10 g/dL 155 (17) 41 (17) 196 (17)
 >10 g/dL 750 (83) 207 (83) 957 (83)
 Physician’s diagnosis of anemia – n (%) 419 (37) 135 (48) 554 (39)
 Patients with anemia symptoms – n (%) 368 (33) 88 (31) 456 (32)
Type of symptoma – n (%)
 Fatigue 321 (28) 71 (25) 392 (28)
 Headaches 53 (5) 8 (3) 61 (4)
 Dyspnea 85 (8) 22 (8) 107 (8)
 Loss of libido 45 (4) 6 (2) 51 (4)
 Depression 112 (10) 10 (4) 122 (9)
 Dizziness 31 (3) 11 (4) 42 (3)
 Cold skin 66 (6) 10 (4) 76 (5)
 Palpitations 59 (5) 3 (1) 62 (4)
 Pulmonary edema 0 (0) 0 (0) 0 (0)
 Heart failure 2 (<1) 2 (1) 4 (<1)
 Severe impairment of cognitive function 10 (1) 2 (1) 12 (1)
 Other symptoms possibly related to anemia 6 (1) 6 (2) 12 (1)
Current chemotherapy cycle delayed due to anemia – n (%) 37 (3) 14 (5) 51 (4)

Note:

a

Patients may be included in more than one category.

Abbreviations: CI, confidence interval; SD, standard deviation.